TAM
CORT icon

Tucker Asset Management’s Corcept Therapeutics CORT Stock Holding History

Tucker Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-349
Closed -$17.6K – 424
2024
Q4 		$17.6K Hold
349
– – ﹤0.01% 599
2024
Q3 		$16.2K Sell
349
-9,657
-97% -$343K ﹤0.01% 591
2024
Q2 		$325K Buy
10,006
+175
+2% +$4.79K 0.07% 103
2024
Q1 		$248K Buy
+9,831
New +$232K 0.06% 149

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Tucker Asset Management's CORT Position: Q1 2025 in Review

Tucker Asset Management sold out of Corcept Therapeutics (CORT) in Q1 2025, closing a stake of 349 shares — an estimated $17.6K sold.

Tucker Asset Management first reported a position in CORT in Q1 2024 and held it in 4 quarters. The position peaked at $325K in Q2 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q1 2025.

  • Tucker Asset Management reported no remaining Corcept Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Tucker Asset Management sold 349 Corcept Therapeutics shares in Q1 2025, an estimated $17.6K.
  • Tucker Asset Management first reported a position in Corcept Therapeutics in Q1 2024 and held it in 4 quarters.
  • Tucker Asset Management's Corcept Therapeutics position peaked at $325K in Q2 2024.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2025.

Based on Tucker Asset Management's 13F filing for Q1 2025, filed 6 Jan 2026.